Pfizer Inc. (NYSE:PFE) has witnessed a drop in its share prices over the last one month. Much can be attributed towards the increasing number of lawsuits from its customer concerned about the side effects of Lipitor. The drug has faced imminent resistance right from the time when Food and Drug Administration (FDA) announced its linkage…